180 related articles for article (PubMed ID: 8491331)
1. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
Bounds W; Szarewski A; Lowe D; Guillebaud J
Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
3. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA
Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278
[TBL] [Abstract][Full Text] [Related]
4. The cervico-vaginal epithelium during 20 cycles' use of a combined contraceptive vaginal ring.
Roumen FJ; Boon ME; van Velzen D; Dieben TO; Coelingh Bennink HJ
Hum Reprod; 1996 Nov; 11(11):2443-8. PubMed ID: 8981130
[TBL] [Abstract][Full Text] [Related]
5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
6. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
7. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
Davies GC; Feng LX; Newton JR; Dieben TO; Coelingh-Bennink HJ
Contraception; 1992 May; 45(5):511-8. PubMed ID: 1623721
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
9. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.
Niruthisard S; Roddy RE; Chutivongse S
Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953
[TBL] [Abstract][Full Text] [Related]
10. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
11. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
12. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring.
Weisberg E; Fraser IS; Baker J; Archer D; Landgren BM; Killick S; Soutter P; Krause T; d'Arcangues C
Contraception; 2000 Aug; 62(2):83-9. PubMed ID: 11102592
[TBL] [Abstract][Full Text] [Related]
14. Studies of cervical caps: I. Vaginal lesions associated with use of the Vimule cap.
Bernstein GS; Kilzer LH; Coulson AH; Nakamura RM; Smith GC; Bernstein R; Frezieres R; Clark VA; Coan C
Contraception; 1982 Nov; 26(5):443-56. PubMed ID: 7160179
[TBL] [Abstract][Full Text] [Related]
15. Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytology.
Schwan A; Ahrén T; Victor A
Contraception; 1983 Oct; 28(4):341-7. PubMed ID: 6667623
[TBL] [Abstract][Full Text] [Related]
16. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
[TBL] [Abstract][Full Text] [Related]
17. [The clinico-morphological and cytological characteristics of the ecto- and endocervix with the use of the oral contraceptive triregol].
Prilepskaia VN; Nazarova NM; Kondrikov NI
Akush Ginekol (Mosk); 1993; (3):30-3. PubMed ID: 8048684
[TBL] [Abstract][Full Text] [Related]
18. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
Hickey M; Fraser I; Dwarte D; Graham S
Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
[TBL] [Abstract][Full Text] [Related]
19. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
20. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia.
Moscicki AB; Winkler B; Irwin CE; Schachter J
J Pediatr; 1989 Sep; 115(3):487-93. PubMed ID: 2769512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
